1. Home
  2. TPST vs CLST Comparison

TPST vs CLST Comparison

Compare TPST & CLST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TPST
  • CLST
  • Stock Information
  • Founded
  • TPST 2011
  • CLST 1922
  • Country
  • TPST United States
  • CLST United States
  • Employees
  • TPST N/A
  • CLST N/A
  • Industry
  • TPST Biotechnology: Pharmaceutical Preparations
  • CLST
  • Sector
  • TPST Health Care
  • CLST
  • Exchange
  • TPST Nasdaq
  • CLST Nasdaq
  • Market Cap
  • TPST 45.5M
  • CLST 54.6M
  • IPO Year
  • TPST N/A
  • CLST N/A
  • Fundamental
  • Price
  • TPST $10.45
  • CLST $13.25
  • Analyst Decision
  • TPST Hold
  • CLST
  • Analyst Count
  • TPST 3
  • CLST 0
  • Target Price
  • TPST $30.00
  • CLST N/A
  • AVG Volume (30 Days)
  • TPST 47.7K
  • CLST 7.6K
  • Earning Date
  • TPST 11-11-2025
  • CLST 10-23-2025
  • Dividend Yield
  • TPST N/A
  • CLST N/A
  • EPS Growth
  • TPST N/A
  • CLST N/A
  • EPS
  • TPST N/A
  • CLST 0.60
  • Revenue
  • TPST N/A
  • CLST $11,340,000.00
  • Revenue This Year
  • TPST N/A
  • CLST N/A
  • Revenue Next Year
  • TPST N/A
  • CLST N/A
  • P/E Ratio
  • TPST N/A
  • CLST $22.22
  • Revenue Growth
  • TPST N/A
  • CLST 133.67
  • 52 Week Low
  • TPST $5.35
  • CLST $10.67
  • 52 Week High
  • TPST $15.73
  • CLST $14.23
  • Technical
  • Relative Strength Index (RSI)
  • TPST 49.98
  • CLST 55.30
  • Support Level
  • TPST $10.09
  • CLST $13.24
  • Resistance Level
  • TPST $10.79
  • CLST $13.34
  • Average True Range (ATR)
  • TPST 0.68
  • CLST 0.06
  • MACD
  • TPST -0.11
  • CLST -0.02
  • Stochastic Oscillator
  • TPST 16.93
  • CLST 29.54

About TPST Tempest Therapeutics Inc.

Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.

About CLST Catalyst Bancorp Inc.

Catalyst Bancorp Inc is a bank holding company. Through its subsidiary, which is a federally chartered community-oriented savings bank, it is engaged in attracting deposits from the general public and using those funds to invest in loans and securities. The sources of funds are customer deposits, repayments of loans, maturities of investments, and funds borrowed from outside sources, which are used for the origination of loans. It derives income principally from interest earned on loans and investment securities and, to a lesser extent, from fees received in connection with the origination of loans, service charges on deposit accounts, and other services.

Share on Social Networks: